Selling your distribution business? Know what it is really worth.
Medical device distribution sits at the intersection of two powerful acquisition trends: healthcare PE consolidation and supply chain resilience. Distributors with established hospital and ASC relationships, GPO contract access, and regulatory compliance infrastructure are commanding premium valuations as manufacturers prefer established channel partners over direct sales forces. The shift toward outpatient procedures is creating new distribution opportunities that nimble independent distributors are uniquely positioned to serve.
Strategic acquirers including device manufacturers and GPO-aligned distributors, PE firms with healthcare platform strategies, and larger regional distributors adding product lines or geographic coverage. Henry Schein, Owens and Minor, and Medline are active in feeder acquisitions.
Exclusive distribution agreements and product line specialization — a distributor with exclusive territorial rights to a high-demand device category trades at 6–7x. Non-exclusive commodity distributors trade at 4x or below.
Multiple ranges are directional and based on general market experience. Market multiples will vary based on your specific geography and market economics. Your valuation will include comparables that will establish your specific range of value.
The factors that push multiples to the top of the range.
Not all medical device distribution businesses are created equal in the eyes of a buyer. The spread across the multiple range is enormous. Here is what separates the top from the bottom.
Exclusive distribution agreements
Territorial or product-line exclusivity with one or more manufacturers is the highest-value asset. Exclusive agreements guarantee margin, eliminate price competition, and create a captive relationship. Buyers pay the highest multiples for multi-year exclusive agreements with auto-renewal provisions and territorial protection.
GPO contract access and compliance
Group Purchasing Organization membership — Vizient, Premier, HealthTrust — is the gateway to hospital purchasing. Distributors on GPO contracts have access to formulary-listed products and established pricing, removing the biggest barrier to hospital sales. GPO compliance infrastructure is hard to replicate.
Regulatory and quality infrastructure
FDA registration, ISO 13485 certification, state licensing, and documented quality management systems are required for many device categories. Distributors with clean FDA inspection histories eliminate regulatory risk for buyers. This infrastructure takes 12–24 months to build from scratch.
Product specialization and clinical expertise
Distributors with sales teams possessing deep clinical knowledge in a specialty — orthopedics, cardiovascular, wound care — are more valuable than general-line distributors. Clinical expertise creates switching costs because surgeons rely on knowledgeable reps.
ASC and physician office penetration
The shift from hospital to outpatient settings is accelerating. Distributors with established ASC and physician office relationships are positioned for growth. ASC accounts are typically less price-sensitive than hospital GPO purchasing, supporting better margins.
Consignment programs and inventory management
Distributors managing consignment inventory at customer sites — implant trays in ORs, instrument sets in ASCs — create deep operational integration that is extremely difficult for competitors to displace. Effective consignment management is a differentiated service.
The deal structures owners need to know.
PE and strategic acquisitions
Deals above $2M EBITDA are predominantly PE-backed or strategic acquisitions, structured as stock or asset purchases with 70–80% cash at close and 15–25% in seller notes or earnouts. Earnouts are tied to revenue maintenance and key account retention over 18–24 months. Strategic acquirers often pay all-cash premiums for exclusive distribution rights.
SBA financing for smaller deals
SBA 7(a) financing is available for smaller deals but lenders require evidence of durable manufacturer relationships and examine contract termination provisions closely. Inventory valuation is a significant closing item — medical device inventory can represent $500K–$5M+.
Manufacturer consent
Manufacturer consent to assignment of distribution agreements is the most critical deal contingency. Distribution agreements almost universally contain anti-assignment clauses, and manufacturer approval can take 30–90 days. Buyers often begin relationship-building during LOI.
Regulatory transfer
FDA establishment registration, state licenses, and DEA registration must transfer or be re-issued to the buyer. Consignment inventory — owned by the manufacturer, held by the distributor — must be carefully documented and excluded from asset valuation.
The value gap
Most device distributors we work with are leaving $400K–$1.5M on the table by not formalizing exclusive territorial agreements with their key manufacturers before selling. Converting handshake exclusivity into contractual exclusivity with auto-renewal can move your multiple a full turn.
The wealth gap
A device distributor doing $8M in revenue with $800K adjusted earnings at a 5.0× multiple walks away with $4.0M before taxes. After capital gains and transaction costs, that may be $3.0M. Is that your freedom number? The wealth gap is the distance between your exit proceeds and the life you want after.
The readiness gap
You built these relationships over decades — surgeons trust your team, hospital purchasing knows your name. That trust built the business — but it also makes it untransferable. If your key accounts cannot be serviced, orders fulfilled, and consignment managed without you for 90 days, the readiness gap is open.
Questions owners actually ask.
What is my medical device distribution business worth? ▸
Medical device distributors typically sell for 3.0–6.0× adjusted earnings. On $800K adjusted earnings, that is a range of $2.4M to $4.8M. Where you fall depends on exclusivity of distribution agreements, GPO access, product specialization, regulatory compliance, and ASC channel penetration. A professional opinion of value gives you the real number.
How important are my exclusive distribution agreements? ▸
They are the single most valuable asset. Exclusive territorial rights to a high-demand device category command premium multiples. If your agreements are handshake-based rather than contractual, formalizing them before sale is one of the highest-ROI pre-exit moves you can make.
Will my manufacturer relationships survive the sale? ▸
This is the #1 risk buyers evaluate. Most distribution agreements contain anti-assignment clauses requiring manufacturer approval of the new owner. Smart deal structuring involves introducing the buyer to key manufacturers during diligence — not after closing. We manage this process to protect your deal.
Does my inventory affect the purchase price? ▸
Significantly. Medical device inventory can represent $500K–$5M+ and must be carefully valued at closing. Buyers negotiate whether inventory is included in the purchase price or purchased at cost separately. Consignment inventory must be documented and excluded from asset valuation.
What can I do in the next 12 months to increase my value? ▸
Three highest-impact moves: (1) Formalize exclusive distribution agreements with contractual territorial protection and auto-renewal. (2) Expand your ASC and physician office channel — this is where growth is headed. (3) Document your regulatory compliance infrastructure and quality management systems. These moves routinely add $500K–$1.5M to a device distribution exit.
Know your number
We value your distribution business using real comps from completed medical device transactions — not generic formulas. You get a professional opinion of value with distribution agreement analysis, GPO contract assessment, and the earnings adjustments specific to device distribution: inventory carrying costs, consignment programs, and regulatory compliance overhead.
Grow your value
If you have runway, Value Growth coaching helps you formalize exclusivity agreements, expand ASC penetration, strengthen regulatory infrastructure, and build sales team depth. Each improvement moves your multiple — and we know which ones device distribution buyers actually pay for.
Sell on your terms
When you are ready, we list the business, screen and qualify buyers (PE platforms, strategic acquirers, larger distributors), negotiate the deal structure including manufacturer consent, and sit at the closing table.
Know what your distribution business is really worth.
The first step costs nothing. Tell us about your business and we will send a market intelligence brief specific to medical device distribution in your geography in 24–48 hours. No forms to fight, no pitch attached.